Initial experience with laser cataract surgery

Article

Exciting advancement in cataract surgery.

Evolution of the technique

Kelman introduced phacoemulsification in 1967 but it wasn't until the curvilinear capsulorrhexis became an integral part that it evolved into the preferred cataract surgery technique. The history of phacoemulsification parallels the introduction of femtosecond laserassisted cataract surgery and highlights the fact that the decision 'when' to adopt any new technology is often difficult In the first instance, for example, we wished to establish that the technique was safe and at least as good as the already excellent results we were achieving with smallincision phacoemulsification.

We published the results of our initial experience in the first 200 eyes undergoing LCS at our centre.1 This multi-surgeon ethics committee approved study identified a number of potential problems and suggested changes to the laser delivery strategy. In the 12 months following installation of the device in April 2011, we have completed over 1500 procedures. The software is under constant evolution and has had several upgrades during this period. Our aim was to understand the techniques better and further improve patient and surgeon satisfaction rates. This was the first prospective study to identify the key issues involved in integrating femtosecond laser cataract surgery into routine clinical practice.

First study

First 200 consecutive eyes operated by six surgeons at our centre were divided into four groups (Group 1–4) comprising 50 eyes each. Exclusion criteria included poor papillary dilation or posterior synechiae as such cases are unsuitable for LCS.

Docking

Initial cohort had an increased number of docking attempts that became less frequent with experience. Patient positioning and the surgeon's verbal communication with the patient are important in docking the 'patient interface' onto the subject's eye. Small palpebral apertures should be noted during preoperative evaluation of patients undergoing LCS. A patient interface with a smaller footprint is being planned for release. Suction breaks occurred in 5 cases (2.5%). These cases proceeded uneventfully with standard cataract surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.